These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 28396946)

  • 1. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
    Amer R; Alsughayyar W; Almeida D
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of Behçet's disease in the Indian population.
    Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
    Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features of patients with Behcet's uveitis].
    Liu XS; Gao F; Zhao C; Zhang MF
    Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):217-223. PubMed ID: 32187951
    [No Abstract]   [Full Text] [Related]  

  • 4. Behçet's disease ocular attack score 24 and visual outcome in patients with Behçet's disease.
    Tanaka R; Murata H; Takamoto M; Ohtomo K; Okinaga K; Yoshida A; Kawashima H; Nakahara H; Fujino Y; Kaburaki T
    Br J Ophthalmol; 2016 Jul; 100(7):990-994. PubMed ID: 26553921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.
    Sota J; Cantarini L; Vitale A; Sgheri A; Gentileschi S; Caggiano V; Gelardi V; Frediani B; Tosi GM; Fabiani C
    Mediators Inflamm; 2020; 2020():6872402. PubMed ID: 32508524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
    Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
    Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
    Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
    Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E; Leccese P; Olivieri I; Latanza L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between optical coherence tomography findings and visual acuity of Behcet's disease-associated uveitis patients during remission stage].
    Zhou W; Yang Z; Liu X; Han X; Zhang M
    Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):746-9. PubMed ID: 26693769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behcet's disease with uveitis in Taiwan.
    Chung YM; Lin YC; Tsai CC; Huang DF
    J Chin Med Assoc; 2008 Oct; 71(10):509-16. PubMed ID: 18955185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.
    Bazvand F; Zarei M; Ebrahimiadib N; Karkhaneh R; Davoudi S; Soleimanzadeh M; Sharifian E; Roohipoor R; Modjtahedi BS
    Semin Ophthalmol; 2017; 32(6):764-771. PubMed ID: 27715380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pars plana vitrectomy for ocular complications of Behçet's disease.
    Sullu Y; Alotaiby H; Beden U; Erkan D
    Ophthalmic Surg Lasers Imaging; 2005; 36(4):292-7. PubMed ID: 16156145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Manifestations in Late Onset Behçet's Disease.
    Saadouli D; Mansour KB; Yahyaoui S; Afrit NE; Lahmar A; Afrit AE
    Curr Aging Sci; 2021; 14(1):56-61. PubMed ID: 31994475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular manifestations in Behçet's disease].
    Zeghidi H; Saadoun D; Bodaghi B
    Rev Med Interne; 2014 Feb; 35(2):97-102. PubMed ID: 24290834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveitis in Behçet disease: an analysis of 880 patients.
    Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
    Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Remission with Upadacitinib in Two Patients with Anti-TNF-Refractory Macular Edema Associated with Behçet's Uveitis.
    Tao T; He D; Peng X; Huang Z; Su W
    Ocul Immunol Inflamm; 2024 Oct; 32(8):1897-1900. PubMed ID: 37801670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular manifestations in Behçet's disease].
    Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
    Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile and management with immunosuppressants and biologics in Behcet's uveitis: A cohort of 25 patients from a tertiary eye care center in South India.
    Ramdoss J; Singh P; Ahmed AS; Biswas J
    Indian J Ophthalmol; 2023 May; 71(5):1972-1976. PubMed ID: 37203067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity.
    Thorne JE; Wittenberg S; Jabs DA; Peters GB; Reed TL; Kedhar SR; Dunn JP
    Ophthalmology; 2006 Dec; 113(12):2310-6. PubMed ID: 16996607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.